- Home
- SKYH vs CRNX Comparison
SKYH vs CRNX Comparison
Compare SKYH & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYH
- CRNX
- Stock Information
- Founded
- SKYH 2017
- CRNX 2008
- Country
- SKYH United States
- CRNX United States
- Employees
- SKYH N/A
- CRNX N/A
- Industry
- SKYH Military/Government/Technical
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- SKYH Industrials
- CRNX Health Care
- Exchange
- SKYH Nasdaq
- CRNX Nasdaq
- Market Cap
- SKYH 325.2M
- CRNX 2.8B
- IPO Year
- SKYH N/A
- CRNX 2018
- Fundamental
- Price
- SKYH $9.97
- CRNX $30.48
- Analyst Decision
- SKYH Strong Buy
- CRNX Strong Buy
- Analyst Count
- SKYH 3
- CRNX 10
- Target Price
- SKYH $14.83
- CRNX $75.00
- AVG Volume (30 Days)
- SKYH 179.1K
- CRNX 654.7K
- Earning Date
- SKYH 08-12-2025
- CRNX 08-07-2025
- Dividend Yield
- SKYH N/A
- CRNX N/A
- EPS Growth
- SKYH N/A
- CRNX N/A
- EPS
- SKYH N/A
- CRNX N/A
- Revenue
- SKYH $17,950,000.00
- CRNX $760,000.00
- Revenue This Year
- SKYH $122.85
- CRNX $402.12
- Revenue Next Year
- SKYH $45.30
- CRNX $770.88
- P/E Ratio
- SKYH N/A
- CRNX N/A
- Revenue Growth
- SKYH 102.32
- CRNX N/A
- 52 Week Low
- SKYH $8.26
- CRNX $24.10
- 52 Week High
- SKYH $14.52
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- SKYH 48.84
- CRNX 50.56
- Support Level
- SKYH $9.75
- CRNX $28.98
- Resistance Level
- SKYH $10.04
- CRNX $30.34
- Average True Range (ATR)
- SKYH 0.28
- CRNX 1.11
- MACD
- SKYH 0.09
- CRNX -0.01
- Stochastic Oscillator
- SKYH 71.13
- CRNX 66.46
About SKYH Sky Harbour Group Corporation
Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.